Which is considered first-line pharmacotherapy for ADHD?

Which is considered first-line pharmacotherapy for ADHD?

• A. Mood stabilizers
• B. Antipsychotics
• C. Nonstimulants
• D. Sympathomimetic stimulants (e.g., methylphenidate)

Answer: (D)

Stimulant medications are the first-line pharmacotherapy for ADHD. Drugs like methylphenidate increase the brain’s available dopamine and norepinephrine, especially in the prefrontal cortex, which is key for attention, executive control, and impulse regulation. This combination typically produces rapid and robust improvement in core ADHD symptoms, making them the go-to option for most patients. They come in short- and long-acting forms, so treatment can be tailored to daytime needs and school schedules. Nonstimulants are useful when stimulants aren’t tolerated, aren’t effective, or aren’t appropriate due to risk factors or misuse concerns, but they generally have slower onset and sometimes less robust symptom control. Mood stabilizers and antipsychotics aren’t first-line for ADHD; they’re targeted at other conditions or specific comorbid features rather than core ADHD symptoms.

Stimulant medications are the first-line pharmacotherapy for ADHD. Drugs like methylphenidate increase the brain’s available dopamine and norepinephrine, especially in the prefrontal cortex, which is key for attention, executive control, and impulse regulation. This combination typically produces rapid and robust improvement in core ADHD symptoms, making them the go-to option for most patients. They come in short- and long-acting forms, so treatment can be tailored to daytime needs and school schedules.

Nonstimulants are useful when stimulants aren’t tolerated, aren’t effective, or aren’t appropriate due to risk factors or misuse concerns, but they generally have slower onset and sometimes less robust symptom control. Mood stabilizers and antipsychotics aren’t first-line for ADHD; they’re targeted at other conditions or specific comorbid features rather than core ADHD symptoms.